SFSIG
GDRX icon

San Francisco Sentry Investment Group’s GoodRx Holdings GDRX Stock Holding History

San Francisco Sentry Investment Group’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-92
Closed -$4K – 714
2021
Q1 		$4K Buy
+92
New +$4.14K ﹤0.01% 612

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Silver Lake Group
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
Atreides Management
Atreides Management Boston, Massachusetts $14.3B AUM 116.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $24B AUM 39.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Carmignac Gestion
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return

San Francisco Sentry Investment Group's GDRX Position: Q2 2021 in Review

San Francisco Sentry Investment Group sold out of GoodRx Holdings (GDRX) in Q2 2021, closing a stake of 92 shares — an estimated $4K sold.

San Francisco Sentry Investment Group first reported a position in GDRX in Q1 2021 and held it in 1 quarter. The position peaked at $4K in Q1 2021. 200 funds tracked by Wall St. Rank hold GDRX as of Q2 2021.

  • San Francisco Sentry Investment Group reported no remaining GoodRx Holdings position as of Q2 2021 after selling out during the quarter.
  • San Francisco Sentry Investment Group sold 92 GoodRx Holdings shares in Q2 2021, an estimated $4K.
  • San Francisco Sentry Investment Group first reported a position in GoodRx Holdings in Q1 2021 and held it in 1 quarter.
  • San Francisco Sentry Investment Group's GoodRx Holdings position peaked at $4K in Q1 2021.
  • 200 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2021.

Based on San Francisco Sentry Investment Group's 13F filing for Q2 2021, filed 2 Aug 2021.